0001447362-23-000179.txt : 20231212
0001447362-23-000179.hdr.sgml : 20231212
20231212193903
ACCESSION NUMBER: 0001447362-23-000179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231209
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oelschlager Kristen M
CENTRAL INDEX KEY: 0001856565
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 231482602
MAIL ADDRESS:
STREET 1: C/O CASTLE BIOSCIENCES
STREET 2: 505 S. FRIENDSWOOD DRIVE, SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770701774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 S FRIENDSWOOD DRIVE
STREET 2: SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 505 S FRIENDSWOOD DRIVE
STREET 2: SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
4
1
wk-form4_1702427930.xml
FORM 4
X0508
4
2023-12-09
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001856565
Oelschlager Kristen M
C/O CASTLE BIOSCIENCES, INC.
505 S FRIENDSWOOD DRIVE, SUITE 401
FRIENDSWOOD
TX
77546
0
1
0
0
Chief Operating Officer
0
Common Stock
2023-12-09
4
M
0
15961
0
A
136061
D
Common Stock
2023-12-09
4
F
0
4206
20.17
D
131855
D
Common Stock
2023-12-10
4
M
0
6170
0
A
138025
D
Common Stock
2023-12-10
4
F
0
1626
20.17
D
136399
D
Common Stock
2023-12-10
4
M
0
1750
0
A
138149
D
Common Stock
2023-12-10
4
F
0
462
20.17
D
137687
D
Restricted Stock Units
2023-12-09
4
M
0
15961
0
D
Common Stock
15961
47883
D
Restricted Stock Units
2023-12-10
4
M
0
6170
0
D
Common Stock
6170
12339
D
Restricted Stock Units
2023-12-10
4
M
0
1750
0
D
Common Stock
1750
1750
D
Includes 759 and 427 shares acquired on February 28, 2023, and August 31, 2023, respectively, under the Issuer's employee stock purchase plan.
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
On December 9, 2022, the Reporting Person was granted 63,844 RSUs, which vest in four equal annual installments beginning on December 9, 2023.
On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.
On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.
/s/ Frank Stokes, Attorney-in-fact
2023-12-12